Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer

Z H Wang1, B Shen, H L Yao

  • 1The Obstetrics and Gynecology Hospital of Medical Center of Fudan University, Shanghai, China.

Oncogene
|February 22, 2007
PubMed

Insights

Intermediate-conductance calcium-activated potassium (IKCa1) channels are crucial for endometrial cancer (EC) development. Inhibiting these channels suppressed EC cell proliferation and tumor growth in mice, suggesting IKCa1 as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Ion Channel Physiology

Background:

  • Potassium channels influence tumor cell proliferation.
  • The role of potassium channels in endometrial cancer (EC) pathogenesis is not well understood.

Purpose of the Study:

  • To investigate the role of intermediate-conductance calcium-activated potassium (IKCa1) channels in endometrial cancer development.

Main Methods:

  • Quantitative analysis of IKCa1 mRNA and protein expression in EC tissues versus normal and pre-cancerous tissues.
  • In vitro studies using EC cell lines treated with IKCa1 inhibitors (clotrimazole, TRAM-34) or IKCa1 siRNA.
  • Electrophysiological recordings to measure IKCa1 currents.
  • In vivo tumor formation studies in nude mice.

Main Results:

  • IKCa1 expression is significantly upregulated in EC tissues.
  • IKCa1 inhibition or downregulation suppressed EC cell proliferation and induced G(0)/G(1) cell cycle arrest.
  • IKCa1 specific currents were detected and inhibited by clotrimazole, TRAM-34, and charybdotoxin.
  • IKCa1 inhibitors reduced tumor formation in vivo.

Conclusions:

  • Increased activity of intermediate-conductance calcium-activated potassium (IKCa1) channels is essential for endometrial cancer development.
  • IKCa1 represents a potential therapeutic target for endometrial cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...